NCT00219570View on ClinicalTrials.gov

Dalacin-T Gel Post Approval Study

PHASE4CompletedINTERVENTIONAL

Enrollment

134

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

June 30, 2005

Conditions

Acne Vulgaris

Interventions

DRUG

clindamycin

DRUG

nadifloxacin

Sponsors

Lead Sponsor

Collaborators (2)

All Listed Sponsors

collaborator

Parexel

INDUSTRY

collaborator

SACT INTERNATIONAL Co., LTD.

UNKNOWN

collaborator

Acronet

INDUSTRY

collaborator

Bellsystem24 , Inc.

INDUSTRY

collaborator

Mitsubishi Kagaku Bio-Clinical Laboratories, inc

INDUSTRY

collaborator

SATO Pharmaceutical Co., Ltd.

INDUSTRY

lead

Pfizer

INDUSTRY